The National Quality Forum has endorsed additional cancer care and population health measures.
The 16 cancer quality measures relate to the diagnosis and treatment of breast and colon cancers, while the five population health quality measures focus on community interventions.
Here are the cancer and population health measures, respectively:
• 0223: Adjuvant chemotherapy is considered or administered within four months (120 days) of surgery to patients under the age of 80 with AJCC III (lymph node positive) colon cancer (Commission on Cancer, American College of Surgeons)
• 0225: At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer (Commission on Cancer, American College of Surgeons)
• 0385: Oncology: Chemotherapy for Stage IIIA through IIIC Colon Cancer Patients (AMA-PCPI)
• 0392: Colorectal Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade (College of American Pathologists)
• 1859: KRAS gene mutation testing performed for patients with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy (American Society of Clinical Oncology)
• 1860: Patients with metastatic colorectal cancer and KRAS gene mutation spared treatment with anti-epidermal growth factor receptor monoclonal antibodies (American Society of Clinical Oncology)
• 0219: Post breast conservation surgery irradiation (Commission on Cancer, American College of Surgeons)
• 0220: Adjuvant hormonal therapy (Commission on Cancer, American College of Surgeons)
• 0221: Needle biopsy to establish diagnosis of cancer precedes surgical excision/resection (Commission on Cancer, American College of Surgeons)
• 0391: Breast Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade (College of American Pathologists)
• 0559: Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under 70 with AJCC T1c, or Stage II or III hormone receptor negative breast cancer (American College of Surgeons)
• 0387: Oncology: Hormonal therapy for stage IC through IIIC, ER/PR positive breast cancer (AMA-PCPI)
• 1857: Patients with breast cancer and negative or undocumented human epidermal growth factor receptor 2 (HER2) status who are spared treatment with trastuzumab (American Society of Clinical Oncology)
• 1855: Quantitative HER2 evaluation by IHC uses the system recommended by the ASCO/CAP guidelines (College of American Pathologists)
• 1858: Trastuzumab administered to patients with AJCC stage I (T1c) – III and human epidermal growth factor receptor 2 (HER2) positive breast cancer who receive adjuvant chemotherapy (American Society of Clinical Oncology)
• 1878: Human epidermal growth factor receptor 2 (HER2) testing in breast cancer (American Society of Clinical Oncology)
• 1999: Late HIV Diagnosis (CDC)
• 2020: Adult Current Smoking Prevalence (CDC)
• 0421: Preventive care and screening: Body Mass Index (BMI) Screening and Follow-Up (CMS)
• 0024: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (NCQA)
• 0029: Counseling on Physical Activity in Older Adults – a. Discussing Physical Activity, b. Advising Physical Activity (NCQA)
The 16 cancer quality measures relate to the diagnosis and treatment of breast and colon cancers, while the five population health quality measures focus on community interventions.
Here are the cancer and population health measures, respectively:
• 0223: Adjuvant chemotherapy is considered or administered within four months (120 days) of surgery to patients under the age of 80 with AJCC III (lymph node positive) colon cancer (Commission on Cancer, American College of Surgeons)
• 0225: At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer (Commission on Cancer, American College of Surgeons)
• 0385: Oncology: Chemotherapy for Stage IIIA through IIIC Colon Cancer Patients (AMA-PCPI)
• 0392: Colorectal Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade (College of American Pathologists)
• 1859: KRAS gene mutation testing performed for patients with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy (American Society of Clinical Oncology)
• 1860: Patients with metastatic colorectal cancer and KRAS gene mutation spared treatment with anti-epidermal growth factor receptor monoclonal antibodies (American Society of Clinical Oncology)
• 0219: Post breast conservation surgery irradiation (Commission on Cancer, American College of Surgeons)
• 0220: Adjuvant hormonal therapy (Commission on Cancer, American College of Surgeons)
• 0221: Needle biopsy to establish diagnosis of cancer precedes surgical excision/resection (Commission on Cancer, American College of Surgeons)
• 0391: Breast Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade (College of American Pathologists)
• 0559: Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under 70 with AJCC T1c, or Stage II or III hormone receptor negative breast cancer (American College of Surgeons)
• 0387: Oncology: Hormonal therapy for stage IC through IIIC, ER/PR positive breast cancer (AMA-PCPI)
• 1857: Patients with breast cancer and negative or undocumented human epidermal growth factor receptor 2 (HER2) status who are spared treatment with trastuzumab (American Society of Clinical Oncology)
• 1855: Quantitative HER2 evaluation by IHC uses the system recommended by the ASCO/CAP guidelines (College of American Pathologists)
• 1858: Trastuzumab administered to patients with AJCC stage I (T1c) – III and human epidermal growth factor receptor 2 (HER2) positive breast cancer who receive adjuvant chemotherapy (American Society of Clinical Oncology)
• 1878: Human epidermal growth factor receptor 2 (HER2) testing in breast cancer (American Society of Clinical Oncology)
• 1999: Late HIV Diagnosis (CDC)
• 2020: Adult Current Smoking Prevalence (CDC)
• 0421: Preventive care and screening: Body Mass Index (BMI) Screening and Follow-Up (CMS)
• 0024: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (NCQA)
• 0029: Counseling on Physical Activity in Older Adults – a. Discussing Physical Activity, b. Advising Physical Activity (NCQA)
More Articles on NQF:
10 Guiding Principles for Patient-Centered Care
NQF Awards Mountain States Health Alliance With 2012 National Quality Healthcare Award
NQF Removes Time-Limited Endorsement for 13 Measures